PATENT CLAIM ANALYSIS

Application Number: 15764730
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "004900"]

Abstract:
The disclosure is related to a method of treating a disorder, such as obesity or a condition associated with obesity, such as hyperphagia, in a subject using a melanocortin-4 receptor (MC4R) agonist.

Claim (Index 5):
A unit dosage any of the compounds of  claims 1 - 3 , wherein the unit dosage contains 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 15, 20, 25, 30, 35, 40, 45, 50 or 100 mg of the compound.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775916', '14800627', '15442229', '13057966', '13074565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8186517226003858
- 35 USC 102 Novelty (BERT): 0.5526103718365273
- Combined Prediction Score: 0.792047587524
- Mean Citation Score: 408.489952
- Max Citation Score: 437.57434000000006
- Similarity Product: 306.0165711700941

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test